English (United Kingdom) 
Español (España) 
The new CBGP Green BioFactory for Health makes it possible to massively produce biomolecules of health interest in plants and to respond to future pandemics and other health challenges.
The CBGP has presented today the results of the research activities and the infrastructures of its multidisciplinary project PANGREEN-CM, which is part of the Agreement between the Community of Madrid (Consejería de Educación. Universidades, Investigación y Portavocia) and the Technical University of Madrid (UPM) for the direct concession of support to finance research projects on SARS-COV2 and the COVID 19 disease financed with REACT-EU resources from the European Regional Development Fund. The objective of these resources has been to deepen the study and characterization of SARS-COV2 (including the new variants), and the development of new solutions to deal with the diagnosis of the disease. Likewise, with these funds the Community of Madrid has tried to provide to its Universities, Hospitals and IMDEAS Institutes with new cutting-edge infrastructures to face new pandemics or health emergencies.
The CBGP within the PANGREEN-CM project has developed different very innovative technologies to deal with SARS-COV2 and future pandemics, developing Computational and Synthetic Biology tools and using plants as biofactories for the production of different biomolecules (antigens, metabolites, etc.) of health interest to deal with these diseases. Within the infrastructure line of the PANGREEN-CM Project, the CBGP has reinforced its existing infrastructures, such as a P3 Biological Safety laboratory that has allowed CBGP researches to work on the development of new SARS-COV2 diagnostic kits during the pandemic. With the help of PANGREEN-CM, a new infrastructure has been created, the Green BioFactory for Health (GreenBIO4H) of the CBGP, for cheap, rapid and massive production in plants of new proteins/peptides and other biomolecules with potential use in biohealth, as antigens in diagnostic tests or molecules to use in therapies. With this project, the available infrastructures have been improved to guarantee the scalability and optimize the performance of the GreenBio4H, providing coverage to most of the R+D+i agents of the Community of Madrid, allowing them to lead the production of biomolecules of health interest in plants and respond to future pandemics and other health challenges.
About CBGP (UPM-INIA/CSIC)
The mission of the CBGP (UPM-INIA/CSIC) is to carry out fundamental and strategic research within the field of plant biology and microorganisms that interact with plants. The research carried out by the different groups of the Centre is aimed at understanding, from a multidisciplinary point of view, essential processes such as the development of plants, their interaction with the environment and the molecular mechanisms that regulate plant nutrition. Likewise, the CBGP (UPM-INIA/CSIC) develops new tools for computational biology and genomics to achieve these objectives. The acquisition of basic biological knowledge is essential to combat the challenges facing agricultural and forestry production and should contribute to the development of new biotechnological solutions. The CBGP (UPM-INIA/CSIC) also plays a relevant role as an educational institution, being a reference centre for the training of young scientists and Master's and Degree students in the areas of Plant Biotechnology and Genomics.